Jag Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Jag Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Sep 01, 2023	BUY	$62.39 - $113.8 $7,798 - $14,225	125 New	125 $14,000
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $9.44 Million - $13.6 Million	-160,287 Reduced 88.2%	21,450 $1.33 Million
Q2 2022 Aug 01, 2022	BUY	$79.4 - $116.36 $14.4 Million - $21.1 Million	181,737 New	181,737 $14.5 Million
Q1 2022 May 11, 2022	SELL	$86.42 - $109.81 $16.7 Million - $21.2 Million	-193,200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $446,969 - $543,791	-4,535 Reduced 2.29%	193,200 $20.8 Million
Q3 2021 Oct 21, 2021	BUY	$91.91 - $110.37 $18.2 Million - $21.8 Million	197,735 New	197,735 $21.7 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Jag Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Jag Capital Management, LLC with notifications on news.